Endometrial cancer

• A study of STX-478 alone and in combination with other anticancer drugs in participants with advanced solid tumors. Recruiting
  2023-504807-94-00 7 2023-12-26 "Breast Cancer; Advanced solid tumors including but not limit"
• Neo-adjuvant pembroliuzmab as an alternative treatment for MMRd uterine cancer Recruiting
  2024-516736-10-00 4 2023-12-18 "Mismatch repair deficient endometrial cancer / uterine cance"
• Roll Over Study for Patients Who Have Completed a Previous Oncology Study with Olaparib Recruiting
  2024-512982-15-00 5 2021-06-28 "BRCA Mutated Ovarian Cancer Patients, Epithelian ovarian can"
• Study of REGN4018 (Ubamatamab) Administered Alone or in Combination with Cemiplimab in Adult Patients with Recurrent Ovarian Cancer or Other … Recruiting
  2024-510783-23-00 7 2020-10-29 "Fallopian Tube Cancer"
• Phase 2 Pan-Tumor Trial of R-DXd for Advanced/Metastatic Solid Tumors Recruitment ended
  2024-513307-13-00 4 2025-05-26 "Advanced/metastatic solid tumors including gynecological can"
• A Study of Giredestrant in Patients with Grade 1 Endometrial Cancer Recruitment ended
  2023-504091-23-00 4 2023-03-14 "Grade 1 Endometrial Cancer"
• An Open-Label Phase 1/2 Trial to Evaluate the Safety, Tolerability, and Efficacy of MORAb 202 in Subjects with Selected Tumor Types. Recruitment ended
  2023-506868-14-00 9 2023-02-28 "Solid tumors in 4 tumor types: platinum resistant ovarian ca"
• Randomized phase III trial in MMR deficient endometrial cancer patients comparing chemotherapy alone versus Dostarlimab in first line advanc … Recruitment ended
  2023-510097-14-00 5 2022-04-15 "Patients with MMR deficient relapse or advanced / metastatic"
• An Umbrella Study of INCMGA00012 Alone and in Combination With Other Therapies in Participants With Advanced or Metastatic Endometrial Cance … Recruitment ended
  2022-502600-79-00 4 2021-03-16
• RANDOMIZED STUDY COMPARING SENTINEL NODE POLICY TO CURRENT INITIAL STAGING PROTOCOLS IN EARLY STAGE ENDOMETRIAL CARCINOMAS AT INTERMEDIATE A … Recruitment ended
  2024-513079-42-00 5 2015-11-19 "Intermediate-risk, high risk endometrial cancer"
• GEN1046 in Combination With Anticancer Agents for the Treatment of Advanced Endometrial Cancer Ended
  2022-502453-33-00 4 2024-02-26 "Advanced Endometrial Cancer"
• A dose-escalation and expansion study of the safety and pharmacokinetics of XB002 as single-agent and combination therapy in subjects with i … Ended
  2023-508267-69-00 3 2023-08-11 "Subjects with Aadvanced solid tumors for whom life-prolongin"
• A Phase 1 Study of SGN-ALPV in Advanced Solid Tumors Ended
  2022-500094-14-00 1 2022-11-08 "gastroesophageal junction [GEJ] carcinoma"
• A Study of SGN-B7H4V in Advanced Solid Tumors Ended
  2023-503389-22-00 1 2022-08-31 "Fallopian tube cancer"
• A Phase 1 open-label, first-in-human, multi-center, dose escalation and dose expansion study of CLN-619 administered alone or in combination … Ended
  2024-511744-27-00 1 2022-06-27 "Solid tumors, Non-Small Cell Lung Cancer, Cervical Cancer, E"
• Safety and preliminary efficacy trial of BNT142 in patients with CLDN6-positive advanced ovarian, lung, or testicular cancer Ended
  2024-512639-58-00 7 2022-05-07 "Solid Tumors"
• Phase 3 Trial of Maintenance with Selinexor/ Placebo After Combination Chemotherapy for Patients with Advanced or Recurrent Endometrial Canc … Ended
  2024-513167-68-00 5 2017-11-29 "endometrial cancer"
• A Phase 1 study to evaluate IK-930 in subjects with advanced solid tumors Ended
  2022-502622-40-00 1 "Advanced Solid Tumors"

Showing 25–42 of 42 trials